We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michelle Rengarajan MD, PhD

Michelle Rengarajan MD, PhD

Instructor in Medicine, Harvard Medical School; Endocrinologist, Massachusetts General Hospital, Boston, Massachusetts

Dr. Michelle Rengarajan is an endocrinologist at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. Her research in human immunology uses single cell multi-omics and quantitative cell biology to define how hormone production may be preserved in autoimmune endocrine disease. She focuses specifically on autoimmune thyroid disease, type 1 diabetes, and endocrine immune-related adverse events caused by immune checkpoint inhibitors. She earned her MD and PhD from Stanford University, completed her internal medicine residency at Brigham and Women’s Hospital and her clinical and research fellowship in endocrinology at Massachusetts General Hospital.


No disclosures reported.